Long Ideas - Shares of Navidea Biopharmaceuticals (NASDAQ:NAVB) are ready to climb as the PDUFA (FDA action) date for the company’s lead product, Lymphoseek, is approaching. This is … Continue Reading
Read nowQuick Picks - Shares of Celsion Corp. (NASDAQ:CLSN) have climbed 103% since PropThink last wrote on the ThermoDox developer in November, which is due to release pivotal Phase … Continue Reading
Read nowLong Ideas - ViroPharma (NASDAQ:VPHM) updated investors last week at the JP Morgan Healthcare conference, offering 2013 guidance for lead product Cinryze, which was strong. The company expects … Continue Reading
Read nowShort Ideas - Telik, Inc. (NASDAQ:TELK) announced last Friday that the FDA granted its lead candidate, ezatiostat HCL (Telintra), orphan drug designation for the treatment of myelodysplastic syndrome … Continue Reading
Read nowQuick Picks - It looks like BGI-Shenzhen may be close to unequivocally beating out fellow bidder Illumina (NASDAQ:ILMN) in securing a buyout of Complete Genomics (NASDAQ:GNOM). Last Friday, … Continue Reading
Read nowLong Ideas - Halozyme Therapeutics (NASDAQ:HALO) will likely continue to move higher Monday after an upgrade from BMO Capital Markets, which has increased its outlook from Neutral to … Continue Reading
Read nowLong Ideas - PharmAthene Inc. (AMEX:PIP) announced on Thursday that the Delaware Supreme Court heard oral arguments in ongoing litigation with SIGA Technologies (NASDAQ:SIGA), and a previous ruling … Continue Reading
Read now